Related Experiment Video

Updated: Jul 8, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Antiplatelet agents for stroke prevention following transient ischemic attack

Jesse Weinberger1

  • 1Department of Neurology, Mount Sinai School of Medicine, New York, New York 10029, USA. jesswein@pol.net

Southern Medical Journal
|January 8, 2008
PubMed

Insights

Transient ischemic attack (TIA) indicates cerebrovascular ischemia and poses a significant stroke risk. Early intervention with antiplatelet therapy, particularly aspirin plus dipyridamole, is crucial for secondary stroke prevention.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Transient ischemic attack (TIA) serves as a critical marker for cerebrovascular ischemia.
  • TIA patients face a secondary stroke risk comparable to those who have experienced an ischemic stroke.

Purpose of the Study:

  • To evaluate pharmacologic strategies for reducing secondary stroke risk after TIA.
  • To compare the efficacy of different antiplatelet agents and combination therapies in secondary stroke prevention.

Main Methods:

  • Review of existing studies on antiplatelet agents for secondary stroke prevention.
  • Analysis of data on aspirin, clopidogrel, and aspirin plus dipyridamole combination therapy.

Main Results:

  • Aspirin and clopidogrel have shown efficacy in reducing secondary event risk.
  • Clopidogrel has not demonstrated specific efficacy in preventing secondary events post-TIA or stroke.
  • Aspirin plus dipyridamole combination therapy showed additive benefits over aspirin monotherapy.
  • Aspirin plus clopidogrel combination therapy did not show significant benefit over monotherapy and increased bleeding risk.

Conclusions:

  • Early implementation of pharmacologic and non-pharmacologic interventions is vital after TIA.
  • Aspirin plus dipyridamole is an effective combination therapy for secondary stroke prevention.
  • Caution is advised with aspirin plus clopidogrel due to lack of demonstrated benefit and increased bleeding risk.

More Related Videos

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Related Concept Videos

Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...